FDA approves Theratechnologies' Egrifta

FDA approved an NDA from Theratechnologies Inc. (TSX:TH) for Egrifta tesamorelin to treat HIV-infected patients with lipodystrophy. Merck KGaA (Xetra:MRK) has commercialization rights to the analog of...